Troubles liés aux opiacés : Questions médicales fréquentes
Nom anglais: Opioid-Related Disorders
Descriptor UI:D009293
Tree Number:F03.900.647.500
Termes MeSH sélectionnés :
Cognitive Dysfunction
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Troubles liés aux opiacés : Questions médicales les plus fréquentes",
"headline": "Troubles liés aux opiacés : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Troubles liés aux opiacés : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Troubles liés aux opiacés"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Troubles liés à l'usage de substances psychotropes",
"url": "https://questionsmedicales.fr/mesh/D000079524",
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés à l'usage de substances psychotropes",
"code": {
"@type": "MedicalCode",
"code": "D000079524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dépendance à l'héroïne",
"alternateName": "Heroin Dependence",
"url": "https://questionsmedicales.fr/mesh/D006556",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à l'héroïne",
"code": {
"@type": "MedicalCode",
"code": "D006556",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance à la morphine",
"alternateName": "Morphine Dependence",
"url": "https://questionsmedicales.fr/mesh/D009021",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à la morphine",
"code": {
"@type": "MedicalCode",
"code": "D009021",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Surdose d'opiacés",
"alternateName": "Opiate Overdose",
"url": "https://questionsmedicales.fr/mesh/D000083682",
"about": {
"@type": "MedicalCondition",
"name": "Surdose d'opiacés",
"code": {
"@type": "MedicalCode",
"code": "D000083682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance à l'opium",
"alternateName": "Opium Dependence",
"url": "https://questionsmedicales.fr/mesh/D000074607",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance à l'opium",
"code": {
"@type": "MedicalCode",
"code": "D000074607",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F03.900.647.500.800"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Troubles liés aux opiacés",
"alternateName": "Opioid-Related Disorders",
"code": {
"@type": "MedicalCode",
"code": "D009293",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sharon L Walsh",
"url": "https://questionsmedicales.fr/author/Sharon%20L%20Walsh",
"affiliation": {
"@type": "Organization",
"name": "Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, KT, USA."
}
},
{
"@type": "Person",
"name": "Michelle R Lofwall",
"url": "https://questionsmedicales.fr/author/Michelle%20R%20Lofwall",
"affiliation": {
"@type": "Organization",
"name": "Center on Drug and Alcohol Research, University of Kentucky, Lexington."
}
},
{
"@type": "Person",
"name": "Kevin Y Xu",
"url": "https://questionsmedicales.fr/author/Kevin%20Y%20Xu",
"affiliation": {
"@type": "Organization",
"name": "Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine in St Louis, St Louis, Missouri."
}
},
{
"@type": "Person",
"name": "Richard A Grucza",
"url": "https://questionsmedicales.fr/author/Richard%20A%20Grucza",
"affiliation": {
"@type": "Organization",
"name": "Health and Behavior Research Center, Department of Psychiatry, Washington University School of Medicine in St Louis, St Louis, Missouri."
}
},
{
"@type": "Person",
"name": "Elizabeth E Krans",
"url": "https://questionsmedicales.fr/author/Elizabeth%20E%20Krans",
"affiliation": {
"@type": "Organization",
"name": "Department of Obstetrics, Gynecology & Reproductive Sciences, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, 300 Halket Street, Pittsburgh, PA 15213, USA. Electronic address: kransee@upmc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Montreal Cognitive Assessment Test (MoCA) as a screening tool for cognitive dysfunction in fibromyalgia.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35699063",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.55563/clinexprheumatol/3yxu6p"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update.",
"datePublished": "2023-09-27",
"url": "https://questionsmedicales.fr/article/37834094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms241914647"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Confusion Surrounding Androgen Deprivation Therapy and Cognitive Dysfunction.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37005166",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.euf.2023.03.015"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neuroanatomical Correlates of Cognitive Dysfunction in 22q11.2 Deletion Syndrome.",
"datePublished": "2024-03-30",
"url": "https://questionsmedicales.fr/article/38674375",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/genes15040440"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sex differences in the effects of sleep disorders on cognitive dysfunction.",
"datePublished": "2023-01-27",
"url": "https://questionsmedicales.fr/article/36716906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neubiorev.2023.105067"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Troubles mentaux",
"item": "https://questionsmedicales.fr/mesh/D001523"
},
{
"@type": "ListItem",
"position": 3,
"name": "Troubles liés à une substance",
"item": "https://questionsmedicales.fr/mesh/D019966"
},
{
"@type": "ListItem",
"position": 4,
"name": "Troubles liés à l'usage de substances psychotropes",
"item": "https://questionsmedicales.fr/mesh/D000079524"
},
{
"@type": "ListItem",
"position": 5,
"name": "Troubles liés aux opiacés",
"item": "https://questionsmedicales.fr/mesh/D009293"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Troubles liés aux opiacés - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Troubles liés aux opiacés",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Troubles liés aux opiacés",
"description": "Comment diagnostiquer un trouble lié aux opiacés ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels critères DSM sont utilisés pour le diagnostic ?\nQui peut poser le diagnostic ?\nLe diagnostic peut-il être fait à distance ?",
"url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Cognitive+Dysfunction&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Troubles liés aux opiacés",
"description": "Quels sont les symptômes courants des troubles liés aux opiacés ?\nComment se manifeste le sevrage des opiacés ?\nLes troubles cognitifs sont-ils fréquents ?\nY a-t-il des symptômes physiques associés ?\nLes symptômes varient-ils selon les individus ?",
"url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Cognitive+Dysfunction&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Troubles liés aux opiacés",
"description": "Comment prévenir les troubles liés aux opiacés ?\nLes programmes scolaires aident-ils à la prévention ?\nQuel rôle jouent les médecins dans la prévention ?\nLes campagnes de sensibilisation sont-elles efficaces ?\nComment les familles peuvent-elles aider à prévenir ?",
"url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Cognitive+Dysfunction&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Troubles liés aux opiacés",
"description": "Quels traitements sont disponibles pour les troubles liés aux opiacés ?\nQu'est-ce que la méthadone ?\nComment fonctionne la buprénorphine ?\nLa thérapie de groupe est-elle efficace ?\nQuels sont les effets des traitements médicamenteux ?",
"url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Cognitive+Dysfunction&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Troubles liés aux opiacés",
"description": "Quelles sont les complications des troubles liés aux opiacés ?\nComment les overdoses se produisent-elles ?\nLes troubles cardiaques sont-ils une complication ?\nLes infections sont-elles un risque ?\nLes troubles respiratoires peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Cognitive+Dysfunction&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Troubles liés aux opiacés",
"description": "Quels sont les facteurs de risque des troubles liés aux opiacés ?\nL'âge influence-t-il le risque ?\nLes antécédents de traumatismes augmentent-ils le risque ?\nLe stress est-il un facteur de risque ?\nLes prescriptions médicales abusives sont-elles un risque ?",
"url": "https://questionsmedicales.fr/mesh/D009293?mesh_terms=Cognitive+Dysfunction&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un trouble lié aux opiacés ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des critères cliniques, l'historique d'usage et des évaluations psychologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage de drogues et des évaluations psychologiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels critères DSM sont utilisés pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le DSM-5 utilise des critères spécifiques comme la tolérance et le sevrage pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Qui peut poser le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un professionnel de santé qualifié, comme un médecin ou un psychologue, peut poser le diagnostic."
}
},
{
"@type": "Question",
"name": "Le diagnostic peut-il être fait à distance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des consultations à distance peuvent aider à évaluer les symptômes et poser un diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des troubles liés aux opiacés ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent l'anxiété, la dépression, des troubles de l'humeur et des problèmes physiques."
}
},
{
"@type": "Question",
"name": "Comment se manifeste le sevrage des opiacés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le sevrage peut provoquer des douleurs, des nausées, des tremblements et des troubles du sommeil."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils fréquents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles de la mémoire et de la concentration sont souvent observés chez les utilisateurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes physiques associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la constipation, la fatigue et des douleurs corporelles peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la durée et de la quantité d'usage d'opiacés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles liés aux opiacés ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par l'éducation, la sensibilisation et l'accès à des soins de santé appropriés."
}
},
{
"@type": "Question",
"name": "Les programmes scolaires aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les programmes éducatifs en milieu scolaire peuvent réduire l'usage d'opiacés chez les jeunes."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent les médecins dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins peuvent sensibiliser les patients aux risques liés à l'usage d'opiacés et prescrire judicieusement."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation sont-elles efficaces ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent la conscience des dangers des opiacés et encouragent des comportements sains."
}
},
{
"@type": "Question",
"name": "Comment les familles peuvent-elles aider à prévenir ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les familles peuvent soutenir la communication ouverte et surveiller les comportements à risque."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les troubles liés aux opiacés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie comportementale, la médication et le soutien psychosocial."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la méthadone ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méthadone est un agoniste opioïde utilisé pour traiter la dépendance aux opiacés."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la buprénorphine ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La buprénorphine est un agoniste partiel qui aide à réduire les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "La thérapie de groupe est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie de groupe offre un soutien et des stratégies de coping aux personnes dépendantes."
}
},
{
"@type": "Question",
"name": "Quels sont les effets des traitements médicamenteux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements médicamenteux peuvent réduire les cravings et les symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications des troubles liés aux opiacés ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des problèmes de santé mentale, des maladies infectieuses et des overdoses."
}
},
{
"@type": "Question",
"name": "Comment les overdoses se produisent-elles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les overdoses surviennent souvent par une consommation excessive ou une combinaison avec d'autres substances."
}
},
{
"@type": "Question",
"name": "Les troubles cardiaques sont-ils une complication ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'usage d'opiacés peut entraîner des problèmes cardiaques et des troubles circulatoires."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles un risque ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les utilisateurs d'opiacés injectables sont à risque accru d'infections comme l'hépatite."
}
},
{
"@type": "Question",
"name": "Les troubles respiratoires peuvent-ils survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les opiacés peuvent provoquer des dépressions respiratoires, mettant la vie en danger."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque des troubles liés aux opiacés ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des troubles mentaux et l'accès facile aux opiacés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes et les adolescents sont particulièrement vulnérables aux troubles liés aux opiacés."
}
},
{
"@type": "Question",
"name": "Les antécédents de traumatismes augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes ayant subi des traumatismes sont plus susceptibles de développer des troubles liés aux opiacés."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut augmenter la probabilité de développer une dépendance aux opiacés."
}
},
{
"@type": "Question",
"name": "Les prescriptions médicales abusives sont-elles un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des prescriptions inappropriées ou excessives d'opiacés augmentent le risque de dépendance."
}
}
]
}
]
}
Cognitive dysfunction is one of the criteria for the diagnosis of fibromyalgia (FM) and is typically based on self-report questionnaires such as the Symptom Severity Scale. However, recent studies hav...
Sixty-two FM patients (55 women, 7 men, mean age = 46.17 years, sd=12.56) were administered the MoCA and a computerised cognitive assessment battery. FM symptoms were assessed on the Fibromyalgia Impa...
Moderate positive correlations were found between the MoCA and the computerised cognitive scores as follows: Global Cognitive Score (r=0.493**, p=0.00), Memory Index Score (r= 0.384**, p=0.002), Execu...
The MoCA is an acceptable cognitive screening test for the cognitive evaluation of FM patients....
Cognitive dysfunction is an important non-motor symptom in amyotrophic lateral sclerosis (ALS) that has a negative impact on survival and caregiver burden. It shows a wide spectrum ranging from subjec...
There are varied associations that have been identified between the use of androgen deprivation therapy (ADT) and the development of cognitive decline. We highlight the first studies to evaluate chron...
22q11.2 Deletion Syndrome (22q11.2DS), the most common chromosomal microdeletion, presents as a heterogeneous phenotype characterized by an array of anatomical, behavioral, and cognitive abnormalities...
Sleep is an essential physiological function that sustains human life. Sleep disorders involve problems with the quality, duration, and abnormal behaviour of sleep. Insomnia is the most common sleep d...
Previous studies have shown that multimorbidity is a risk factor for cognitive dysfunction (CD).Type 2 diabetes mellitus (T2DM) and hypertension (HT) are very common risk factors.The association betwe...
To evaluate the association between multimorbidity due to T2DM and HT with CD among adults ≥50 years in Tumbes....
A secondary analysis of a population-based cross-sectional study was conducted. The exposure variable was the presence of both T2DM and HT, split into categories: without HT or T2DM, only T2DM, only H...
688 participants were analyzed. The prevalence of CD was 39.1%. There was a 56.1% of participants without TDM2 nor HT, 8.3% with T2DM, 28.9% with HT and 6.7% with both diseases. A significant associat...
There is association between the morbidity of T2DM and HT, and CD among adults ≥50 years of age in Tumbes. Education was an effect modifier of the association between HT and T2DM on the presence of CD...
Type 2 diabetes (T2DM) is a well known risk factor for Alzheimer's disease. Mitochondria are the center of intracellular energy metabolism and the main source of reactive oxygen species. Mitochondrial...
This review provides an overview of obsessive-compulsive disorder (OCD) symptoms, including the four partially distinct subtypes of the disorder, current diagnostic criteria, and common comorbidities....
This review study was conducted by library method....
We show how dysfunction in cortico-striato-thalamo-cortical (CSTC) circuits may underpin symptoms; and shed light on the putative neurochemistry within these loops such as the role of serotonin, dopam...
In brief, research questions we shed light on include (1) what are the symptoms in OCD; (2) what is the etiology of the disorder and do existing models explain OCD; and (3) what are key cognitive defi...
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease, in which cognitive dysfunction is common, but poorly understood. This study aims to characterize the prevalence and patterns of cogn...
SLE patients (...
The SLE group performed significantly worse than healthy controls on every cognitive test. The largest differences were in the domains of verbal fluency, working memory and attention, while fine motor...
Cognitive dysfunction is common in SLE but markedly heterogeneous across both cognitive domains and across the SLE group. Cluster analysis supports the use of a binary definition of cognitive dysfunct...
A growing body of literature suggests the important role of the thalamus in cognition and neurodegenerative diseases. This study aims to elucidate whether the preoperative thalamic volume is associate...